Schedule 13G ownership disclosure

Elevai Labs Inc.

Common Stock, $0.0001 par value per share · CUSIP: 28622K104

Event date: 2024-08-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Santorio Biomedical, LLC

    Shares: 1,225,000.00 · Class: 5.9%

  • Deniel Mero

    Shares: 1,225,000.00 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002031687-24-000001
Form type
SCHEDULE 13G
Filer
PMGC Holdings Inc.
CIK
CIK 1840563
Filed
Aug 16, 2024
Reporting period
Aug 15, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub